GIT1 Functions asa as a Scaffold for MEK1-Extracellular Signal-Regulated Kinase 1 and 2 Activation by Angiotensin II and Epidermal Growth Factor

Molecular and Cellular Biology

Volumn 24, Issue 2, 2004, Pages 875-885

  Yin, Guoyong ^a   Haendeler, Judith ^a   Yan, Chen ^a   Berk, Bradford C ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; EPIDERMAL GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE INTERACTING PROTEIN 1; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN; PROTEIN SERINE KINASE; PROTEIN TYROSINE KINASE; SCAFFOLD PROTEIN; TYROSINE KINASE COUPLED RECEPTOR; UNCLASSIFIED DRUG; ANGIOTENSIN II; CELL CYCLE PROTEIN; COMPLEMENTARY DNA; GIT1 PROTEIN, HUMAN; GIT1 PROTEIN, MOUSE; GIT1 PROTEIN, RAT; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MAP2K1 PROTEIN, HUMAN; MAP2K1 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; CELL STRAIN; CELL STRAIN HEK 293; COILED COIL DOMAIN; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SPA2 HOMOLOGY DOMAIN; VASCULAR SMOOTH MUSCLE; ANIMAL; BINDING SITE; BIOLOGICAL MODEL; CELL CULTURE; CELL LINE; CHEMISTRY; DRUG EFFECT; GENETICS; HELA CELL; IN VITRO STUDY; METABOLISM; MOUSE; MUTAGENESIS; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; RAT; RNA INTERFERENCE; TWO HYBRID SYSTEM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN II; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL CYCLE PROTEINS; CELL LINE; CELLS, CULTURED; DNA, COMPLEMENTARY; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; GTPASE-ACTIVATING PROTEINS; HELA CELLS; HUMANS; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; MUTAGENESIS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, G-PROTEIN-COUPLED; RNA INTERFERENCE; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0346095319     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.2.875-885.2004     Document Type: Article

References (53)

1. Ali M. S., P. P. Sayeski, L. B. Dirksen, D. J. Hayzer, M. B. Marrero, and K. E. Bernstein. 1997. Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor. J. Biol. Chem. 272:23382-23388.
2. Bagrodia, S., D. Bailey, Z. Lenard, M. Hart, J. L. Guan, R. T. Premont, S. J. Taylor, and R. A. Cerione. 1999. A tyrosine-phosphorylated protein that binds to an important regulatory region on the Cool family of p21-activated kinase-binding proteins, J. Biol. Chem. 274:22393-22400.
3. Belsches, A. P., M. D. Haskell, and S. J. Parsons. 1997. Role of c-Src tyrosine kinase in EGF-induced mitogenesis. Front. Biosci. 2:d501-d518.
4. Berk, B. C. 1999. Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases. J. Am. Soc Nephrol. 10(Suppl. 11):S62-S68.
5. Berk, B. C., V. Vekshtein, H. M. Gordon, and T. Tsuda. 1989. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13:305-314.
6. Bhat, G. J., T. J. Thekkumkara, W. G. Thomas, K. M. Conrad, and K. M. Baker. 1994. Angiotensin II stimulates sis-inducing factor-Iike like DNA binding activity. J. Biol. Chem. 269:31443-31449.
7. Brown, M. C., K. A. West, and C. E. Turner. 2002. Paxillin-dependent paxillin kinase linker and p21-activated kinase localization to focal adhesions involves a multistep activation pathway. Mol. Biol. Cell 13:1550-1565.
8. Buchsbaum, R. J., B. A. Connolly, and L. A. Feig. 2002. Interaction of Rac exchange factors Tiaml and Ras-GRF1 ith a scaffold for the p38 mitogen-activated protein kinase cascade, Mol. Cell. Biol. 22:4073-4085.
9. Claing, A., W. Chen, W. E. Miller, N. Vitale, J. Moss, R. T. Premont, and R. J. Lefkowitz. 2001. β-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis., J. Biol. Chem. 276:42509-42513.
10. Claing, A., S. J. Perry, M. Achiriloaie, J. K. Walker, J. P. Albanesi, R. J. Lefkowitz, and R. T. Premont. 2000. Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity. Proc. Natl. Acad. Sci. USA 97:1119-1124.
11. Di Cesare, A., S. Paris, C. Albertinazzi, S. Dariozzi, J. Andersen, M. Mann, R. Longhi, and I. de Curtis. 2000. p95-APP1 links membrane transport to Rac-mediated reorganization of actin. Nat. Cell Biol. 2:521-530.
12. Ducret, A., I. Van Oostveen, J. K. Eng, J. R. Yates III, and R. Aebersold. 1998. High throughput protein characterization by automated reverse-phase chromatography/electrospray tandem mass spectrometry. Protein Sci. 7:706-719.
13. Eguchi, S., H. Iwasaki, T. Inagami, K. Numaguchi, T. Yamakawa, E. D. Motley, K. M. Owada, F. Marumo, and Y. Hirata. 1999. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension 33:201-206.
14. Fincham, V. J., M. James, M. C. Frame, and S. J. Winder. 2000. Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. EMBO J. 19:2911-2923.
15. Geisterfer, A. A. T., M. J. Peach, and G. K. Owens. 1988. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62:749-756.
16. Ginnan, R., and H. A. Singer. 2002. CaM kinase II-dependent activation of tyrosine kinases and ERK1/2 in vascular smooth muscle. Am. J. Physiol. Cell Physiol. 282:C754-C761.
17. Hanks, S. K., M. B. Calalb, M. C. Harper, and S. K. Patel. 1992. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc. Natl. Acad. Sci. USA 89:8487-8491.
18. Ishida, M., T. Ishida, S. Thomas, and B. C. Berk. 1998. Activation of extracellular signal-regulated kinases (ERK1/2)(ERKI/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ. Res. 82:7-12.
19. c-src in vascular smooth muscle cells. Circ. Res. 77:1053-1059.
20. Klemke, R. L., S. Cai, A. L. Giannini, P. J. Gallagher, P. de Lanerolle, and D. A. Cheresh. 1997. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137:481-492.
21. Kong, M., C. Mounier, V. Dumas, and B. I. Posner. 2003. Epidermal growth factor-induced DNA synthesis. Key role for Src phosphorylation of the docking protein Gab2. J. Biol. Chem. 278:5837-5844.
22. Leu, T. H., and M. C. Maa. 2003. Functional implication of the interaction between EGF receptor and C-SRC. Front. Biosci. 8:S28-S38.
23. Luttrell, L. M., F. L. Roudabush, E. W. Choy, W. E. Miller, M. E. Field, K. L. Pierce, and R. J. Lefkowitz. 2001. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. USA 98:2449-2454.
24. Marrero, M. B., B. Schieffer, W. G. Paxton, L. Heerdt, B. C. Berk, P. Delafontaine, and K. E. Bernstein. 1995. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375:247-250.
25. Matsuura, H., H. Nishitoh, K. Takeda, A. Matsuzawa, T. Amagasa, M. Ito, K. Yoshioka, and H. Ichijo. 2002. Phosphorylation-dependent scaffolding role of JSAP1/JIP3 in the ASK1-JNK signaling pathway. A new mode of regulation of the MA kinase cascade. J. Biol. Chem. 277:40703-40709.
26. Melaragno, M. G., D. A. Wuthrich, V. Poppa, D. Gill, V. Lindner, B. C. Berk, and M. A. Corson. 1998. Increased expression of Axi tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats. Circ. Res. 83:697-704.
27. Muller, J., S. Ory, T. Copeland, H. Piwnica-Worms, and D. K. Morrison. 2001. C-TAK1 regulates Ras signaling by phosphorylatin the MAPK scaffold, KSR1. Mol. Cell 8:983-993.
28. Pouyssegur, J., V. Volmat, and P. Lenormand. 2002. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem. Pharmacol. 64:755-763.
29. Premont, R. T., A. Claing, N. Vitale, J. L. Freeman, J. A. Pitcher, W. A. Patton, J. Moss, M. Vaughan, and R. J. Lefkowitz. 1998. β2 P2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. Proc. Natl. Acad. Sci. USA 95:14082-14087.
30. Premont, R. T., A. Claing, N. Vitale, S. J. Perry, and R. J. Lefkowitz. 2000. The GIT family of ADP-ribosylation factor GTPase-activating proteins. Functional diversity of GIT2 through alternative splicing. J. Biol. Chem. 275:22373-22380.
31. Sabri, A., T. C. Corrinne, and P. A. Lucchesi. 1997. Angiotensin II activates the rich-tyrosine kinase 2 (Pyk2) in vascular smooth muscle. Circulation 96:1-46.
32. Sadoshima, J., and S. Izumo. 1996. The heterotrimeric Gq protein-coupled angiotensin II receptor activates p21ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J. 15:775-787.
33. Sadoshima, J., and S. Izumo. 1993. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Circ. Res. 73:424-438.
34. Schaeffer, H. J., A. D. Catling, S. T. Eblen, L. S. Collier, A. Krauss, and M. J. Weber. 1998. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281:1668-1671.
35. Schieffer, B., W. G. Paxton, Q. Chai, M. B. Marrero, and K. E. Bernstein. 1996. Angiotensin II controls p21ras activity via pp60c-src. J. Biol. Chem. 271:10329-10333.
36. Schlaepfer, D. D., S. K. Hanks, T. Hunter, and P. van der Geer. 1994. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372:786-791.
37. Schlaepfer, D. D., C. R. Hauck, and D. J. Sieg. 1999. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71:435-478.
38. Schmitz, U., M. Ishida, and B. C. Berk. 1997. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma-associated proteins. Characterization of a c-Src-dependent 97-kD protein in vascular smooth muscle cells. Circ. Res., 81:550-557.
39. Schorb, W., T. C. Peeler, N. N. Madigan, K. M. Conrad, and K. M. Baker. 1994. Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. J. Biol. Chem. 269:19626-19632.
40. Sheu, Y. J., B. Santos, N. Fortin, C. Costigan, and M. Snyder. 1998. Spa2p interacts with cell polarity proteins and signaling components involved in yeast cell morphogenesis. Mol. Cell. Biol. 18:4053-4069.
41. Slack-Davis, J. K., S. T. Eblen, M. Zecevic, S. A. Boerner, A. Tarcsafalvi, H. B. Diaz, M. S. Marshall, M. J. Weber, J. T. Parsons, and A. D. Catling. 2003. PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J. Cell Biol. 162:281-291.
42. 2+ mobilization and protein kinase C activation. J. Biol. Chem. 264:526-530.
43. Turner, C. E., M. C. Brown, J. A. Perrotta, M. C. Riedy, S. N. Nikolopoulos, A. R. McDonald, S. Bagrodia, S. Thomas, and P. S. Leventhal. 1999. Paxillin LD4 motif binds PAK and PIX through a novel 95-kD ankyrin repeat, ARF-GAP protein: a role in cytoskeletal remodeling. J. Cell Biol. 145:851-863.
44. van Drogen, F., and M. Peter. 2002. Spa2p functions as a scaffold-like protein to recruit the Mpklp MAP kinase module to sites of polarized growth. Curr. Biol. 12:1698-1703.
45. Vitale, N., W. A. Patton, J. Moss, M. Vaughan, R. J. Lefkowitz, and R. T. Premont. 2000. GIT proteins, a novel family of phosphatidylinositol 3,4,5-trisphosphate-stimulated GTPase-activating proteins for ARF6. J. Biol. Chem. 275:13901-13906.
46. Vuori, K., H. Hirai, S. Aizawa, and E. Ruoslahti. 1996. Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases. Mol. Cell. Biol. 16:2606-2613.
47. Weng, Y. I., and S. D. Shukla. 2002. Angiotensin II activation of focal adhesion kinase and pp60(c-Src) in relation to mitogen-activated protein kinases in hepatocytes. Biochim. Biophys. Acta 1589:285-297.
48. West, K. A., H. Zhang, M. C. Brown, S. N. Nikolopoulos, M. C. Riedy, A. F. Horwitz, and C. E. Turner. 2001. The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL). J. Cell Biol. 154:161-176.
49. Whitmarsh, A. J., J. Cavanagh, C. Tournier, J. Yasuda, and R. J. Davis. 1998. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281:1671-1674.
50. Wunderlich, W., I. Fialka, D. Teis, A. Alpi, A. Pfeifer, R. G. Parton, F. Lottspeich, and L. A. Huber. 2001., A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mpl on a late endosomal/lysosomal compartment. J. Cell Biol. 152:765-776.
51. Xing, H., K. Kornfeld, and A. J. Muslin. 1997. The protein kinase KSR interacts with 14-3-3 protein and Raf. Curr. Biol. 7:294-300.
52. Zama, T., R. Aoki, T. Kamimoto, K. Inoue, Y. Ikeda, and M. Hagiwara. 2002. Scaffold role of a mitogen-activated protein kinase phosphatase, SKRP1, for the JNK signaling pathway. J. Biol. Chem. 277:23919-23926.
53. Zhao, Z. S., E. Manser, T. H. Loo, and L. Lim. 2000. Coupling of PAK-interacting exchange factor PIX to GIT1 promotes focal complex disassembly. Mol. Cell. Biol. 20:6354-6363.